Kevin Outterson

Kevin Outterson is a lawyer, and the N. Neal Pike Scholar in Health and Disability Law at Boston University (2014–present). He is the Executive Director of CARB-X|Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X),[1] a global non-profit partnership focused on accelerating the early development of innovative antibiotics, diagnostics, vaccines and other products to tackle drug-resistant bacterial infections. Outterson's work focuses primarily on law and economics of antibiotic resistance, health law, intellectual property, and global access to medicine.[1]

Kevin Outterson
Alma materNorthwestern University

University of Cambridge

University of Reading
OccupationLaw professor
EmployerBoston University School of Law
Known forHealth Law, Intellectual Property Law, Antibiotic Resistance

Outterson has testified before Congress, the World Health Organization (WHO), and various state legislatures.[2]

He is Co-director of the health law program at Boston University School of Law (2007–present) and associate fellow at the Royal Institute of International Affairs at Chatham House, London (2014–present). He serves on the Board of the American Society of Law, Medicine & Ethics (2010–present), and as faculty editor to the American Journal of Law & Medicine (2007–present). He is past editor-in-chief of the Journal of Law, Medicine & Ethics (2010–2016).[1]

References
  1. "Kevin Outterson | School of Law". www.bu.edu. Retrieved 12 May 2020.
  2. "Professor Kevin Outterson". Chatham House. Retrieved 2020-05-01.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.